Healthcare >> Analyst Interviews >> April 9, 2001
KEN LAUDAN joined Robinson-Humphrey in 2000. He has 10 years of
healthcare investment experience including Senior Research Analyst
positions at Montgomery Securities (now Banc of America Securities) and
Hambrecht & Quist (now Chase H&Q). Since 1992, Mr. Laudan has been
involved with nearly $2 billion worth of healthcare equity and M&A
assignments consisting of 15 different healthcare companies. He also is
a three-time Wall Street Journal All-Star Analyst. Mr. Laudan received a
BS Finance/Accounting from Kansas State University in 1982. Profile
services grouping?
Mr. Laudan: It's really a hybrid portfolio of companies, but with all of
them prescription drug- or
